Stability Testing for Herbal Supplements: What DSHEA Requires and Why Your Expiration Date Is a Legal Claim

That expiration date printed on your supplement label? It’s not a marketing estimate. It’s a factual claim — and under 21 CFR Part 111, the FDA expects hard data behind it.

Herbal supplement manufacturers in the Midwest run into this more often than you’d expect. A contract manufacturer says “we always use 24 months.” A formulator pastes in a date that feels conservative. No stability protocol, no testing matrix, no documentation. The label goes to print. And then an FDA investigator walks in.

Unsupported expiration dates consistently rank among the top 10 most cited observations during dietary supplement CGMP inspections. The relevant section — 111.165(c) — is direct: if you include an expiration date, you must establish it based on stability testing. That’s not guidance language. It’s a requirement. And it applies whether you’re manufacturing in-house or contracting out the work.

What 21 CFR Part 111 Actually Requires from Supplement Brands

The confusion usually starts here: FDA doesn’t require supplement brands to put an expiration date on their label. But if you choose to include one — and nearly every brand does, because consumers expect it — the agency requires that date to be supported by data.

Section 111.165(c) states that you must establish the expiration date based on information you have about the identity, purity, strength, and composition of the component or dietary supplement. That language covers both raw materials and finished products.

Section 111.87(a)(7) compounds this requirement: you must retain reserve samples sufficient to conduct a complete analysis of the batch for at least one year past the product’s expiration date. So not only does the date need data to justify it, you need to keep physical samples long enough for an inspector to independently verify the claims.

FDA’s Compliance Policy Guide 690.100 makes one more thing clear: “best by,” “use by,” and “best before” dates are treated exactly the same as expiration dates for regulatory purposes. There’s no softer phrasing that exempts you from the data requirement.

This trips up brands most often at contract manufacturers where “we always use 2 years” has become the default without ever being backed by a formal study. When the investigator asks for the stability data supporting that claim, “we’ve always done it this way” is not an acceptable answer.

Building a Stability Protocol That Actually Holds Up

Pharmaceutical companies follow ICH Q1A(R2) — the international guideline for stability testing of drug substances and products. Dietary supplement manufacturers aren’t legally obligated to follow it, but FDA inspectors are trained against it, and it’s the closest thing to an established benchmark the supplement industry has.

The core of any stability protocol is storage conditions and timepoints. ICH Q1A(R2) defines three main conditions:

• Long-term: 25°C ± 2°C / 60% RH ± 5% — the standard setting for real-time shelf life generation
• Accelerated: 40°C ± 2°C / 75% RH ± 5% — used to support provisional shelf life claims while real-time data accumulates
• Intermediate: 30°C ± 2°C / 65% RH ± 5% — used when accelerated conditions cause atypical degradation not representative of real-world storage

Standard testing timepoints for a 24-month real-time study run at 0, 3, 6, 9, 12, 18, and 24 months. Accelerated studies test at 0, 3, and 6 months — giving you a faster data package to support provisional labeling decisions.

Here’s the piece most brands don’t fully appreciate: packaging matters as much as conditions. Accelerated data generated from a product in an open container is scientifically meaningless — it doesn’t model your actual shelf storage. All samples must be placed in the final, sealed commercial packaging before chambers are loaded.

For botanical products specifically, there’s an added layer of complexity. Herbal raw materials contain volatile compounds — essential oils, terpenes, moisture-sensitive glycosides — that degrade differently from synthetic small molecules. Peppermint extract, for example, can lose significant amounts of menthol during accelerated storage at 40°C in ways that don’t occur at 25°C over the same interval. For these products, intermediate conditions often generate more meaningful data than accelerated, even though it takes longer to accumulate. That decision should be made before the chambers are loaded, not after you see unexpected degradation in month three.

The Testing Matrix: What an Analytical Testing Laboratory Should Run at Each Timepoint

Not every test is required at every timepoint — that would be prohibitively expensive and scientifically unnecessary. What you need is a well-reasoned matrix that covers identity, potency, microbiological quality, and physical attributes across the study duration.

Here’s how a stability testing matrix typically looks for herbal supplement products:

Identity (HPTLC fingerprinting): Run at T=0, T=6, and T=18 months at minimum. HPTLC fingerprinting documents the marker compound profile of the botanical and tracks whether those phytochemical signatures are degrading over time. This is often the earliest signal that something is going wrong with the botanical extract, and it’s the kind of data an FDA investigator can ask for during a product challenge.

Potency/Assay (HPLC): Run at every timepoint. You’re quantifying the key phytochemical markers — withanolides for ashwagandha, hypericin and hyperforin for St. John’s Wort, ginsenosides for ginseng, bacosides for bacopa monnieri. A greater than 10% decline from initial measured values at any timepoint is a red flag that your claimed shelf life may not be defensible, and it needs to be investigated rather than ignored.

Microbiology (USP <61>/<62>): Run at T=0 and the final timepoint at minimum, with additional pulls at T=12 for products containing high-moisture botanical material. USP <1111> categorizes acceptance criteria for oral dosage forms: for supplements not intended for aqueous preparation, limits are ≤10³ CFU/g for total aerobic count and ≤10² CFU/g for total yeast and mold count. An out-of-specification result at any timepoint means you can’t support the shelf life claim for that interval.

Heavy metals (USP <232>/<233>): Run at T=0 only in most cases, unless the product uses metallic or foil-lined packaging. Lead, arsenic, cadmium, and mercury don’t meaningfully increase during sealed shelf storage — but you need the baseline data on file in case a finished product is ever challenged.

Physical and organoleptic attributes: Run at every timepoint. Appearance, color, odor, tablet or capsule disintegration time, and moisture content via Karl Fischer titration. These are the first things an investigator looks at, and a capsule that’s visibly discolored or has caked contents is a compliance failure regardless of what the HPLC data says.

A well-structured analytical testing laboratory builds this as a formal written protocol before samples go into stability chambers — not a retroactive checklist assembled after data comes back. The protocol needs to specify acceptance criteria at each timepoint, not just list the tests to be performed.

Accelerated vs. Real-Time Data: Understanding the Difference

This is where a lot of supplement brands take shortcuts that create compliance exposure later.

Accelerated stability testing is grounded in the Arrhenius equation — the principle that for every 10°C increase in temperature, chemical reaction rates roughly double (the Q10 factor). Running six months at 40°C theoretically models approximately two years at 25°C. That’s why a completed six-month accelerated study can provisionally support a 24-month expiration date claim while your real-time study is still running.

The critical qualifier is “provisionally.” FDA expects real-time confirmation as those data points become available. If your accelerated study shows a 7% loss of a key marker compound over six months, and your real-time study hits 14% loss at the 18-month pull, you now have a consistency problem — and potentially an unsupported shelf life claim for every batch already in the market.

The other important limitation: if accelerated conditions cause significant, statistically meaningful degradation, you cannot use that data to extrapolate a 24-month real-time claim at all. For botanicals with reactive constituents — licorice root with glycyrrhizin, rosehip extracts with high ascorbic acid content, or any botanical with a high essential oil fraction — accelerated conditions can produce degradation artifacts that simply don’t occur at normal storage temperatures. In those situations, running a real-time study from the beginning of commercialization is the only defensible approach.

A few additional elements that get missed in stability planning:

Multiple manufacturing lots should ideally be included in the study design. Data from a single lot isn’t technically adequate to apply a shelf life claim across all future production, though FDA’s practical enforcement posture on this for supplements has been inconsistent. Building at least two or three lots into your initial study gives you a far stronger position.

Stability chambers must be temperature and humidity qualified, with continuous data logging. A study run in an unqualified chamber — even if all the analytical results look fine — is scientifically invalid and provides no real regulatory defense.

Protocol deviations must be documented. If a chamber excursion occurs mid-study, the impact on data integrity must be assessed, recorded, and evaluated against pre-specified acceptance criteria. Ignoring a documented excursion is worse than not running the study at all.

Before You Print That Expiration Date

If your current shelf life claim rests on “that’s what our contract manufacturer uses” or “we followed what our competitor did,” it’s worth pausing before your next production run.

The practical path forward is straightforward: initiate a stability protocol concurrent with your first commercial batch, using both accelerated and real-time conditions. Let the accelerated data support provisional labeling while real-time confirmation accumulates. Build a testing matrix appropriate to your specific botanical ingredients — not a generic pharmaceutical template adapted without thought. And work with an analytical testing laboratory that structures the protocol correctly at the outset, with written acceptance criteria, calibrated chambers, and a formal review at each timepoint.

An expiration date printed without supporting data isn’t a conservative choice. It’s an unsupported label claim, and every batch shipped under that date carries the same exposure. With a properly designed study in place, it becomes one of the most defensible quality statements on your label.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025-Accredited Supplement Testing at Qalitex Laboratories — Full-panel botanical raw material testing, heavy metals by ICP-MS, and potency assays under ISO 17025 accreditation — the lab behind every Ayah Labs CoA.